(Q34105246)

31 July 2017

1 reference

title

Policosanols as nutraceuticals: fact or fiction (English)

1 reference

31 July 2017

2

Peter J H Jones

1 reference

31 July 2017

Christopher P F Marinangeli

series ordinal

1

1 reference

PubMed ID

20301014

31 July 2017

Amira N Kassis

series ordinal

3

1 reference

PubMed ID

20301014

31 July 2017

Michael N A Eskin

series ordinal

4

1 reference

31 July 2017

1 March 2010

1 reference

Critical Reviews in Food Science and Nutrition

31 July 2017

1 reference

31 July 2017

50

1 reference

31 July 2017

3

1 reference

31 July 2017

259-267

1 reference

Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients

31 July 2017

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

A long-term study of policosanol in the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Modulation of 3-hydroxy-3-methylglutaryl-CoA reductase by changes in microsomal cholesterol content or phospholipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Inflammation, atherosclerosis, and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Lack of effect of sugar cane policosanol on plasma cholesterol in Golden Syrian hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Comparison of composition and absorption of sugarcane policosanols

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Cholesterol-lowering effect of policosanol on rabbits with hypercholesterolaemia induced by a wheat starch-casein diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Inhibition of cholesterol biosynthesis in cultured fibroblasts by D003, a mixture of very long chain saturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Policosanol has no antioxidant activity in human low-density lipoprotein but increases excretion of bile acids in hamsters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Evaluation of peri- and post-natal toxicity of Policosanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Physico-mechanical characterization of policosanol, a novel hypocholesterolemic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Very long chain fatty acids (policosanols) and phytosterols affect plasma lipid levels and cholesterol biosynthesis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effects of policosanols and phytosterols on lipid levels and cholesterol biosynthesis in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10408391003626249

10.1080/10408391003626249

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

20301014